Resistance to anti-orthopoxviral drug tecovirimat (TPOXX®) during the 2022 mpox outbreak in the US

Todd G. Smith, Crystal M. Gigante, Nhien T. Wynn, Audrey Matheny, Whitni Davidson, Yong Yang, Rene Edgar Condori, Kyle O’Connell, Lynsey Kovar, Tracie L. Williams, Yon C. Yu, Brett W. Petersen, Nicolle Baird, David Lowe, Yu Li, Panayampalli S. Satheshkumar, Christina L. Hutson
doi: https://doi.org/10.1101/2023.05.16.23289856

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Back to top
Posted May 18, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Resistance to anti-orthopoxviral drug tecovirimat (TPOXX®) during the 2022 mpox outbreak in the US
Todd G. Smith, Crystal M. Gigante, Nhien T. Wynn, Audrey Matheny, Whitni Davidson, Yong Yang, Rene Edgar Condori, Kyle O’Connell, Lynsey Kovar, Tracie L. Williams, Yon C. Yu, Brett W. Petersen, Nicolle Baird, David Lowe, Yu Li, Panayampalli S. Satheshkumar, Christina L. Hutson
medRxiv 2023.05.16.23289856; doi: https://doi.org/10.1101/2023.05.16.23289856
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area